3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Motor Activity
9
Neoplasms
6
Pancreatic Neoplasms
3
Lung Neoplasms
3
Breast Neoplasms
3
Esophageal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Peripheral Nervous System Diseases
1
Neurocognitive Disorders
1
Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cognitive Dysfunction
1
Interventions
Specimen Handling
38
Biopsy
30
Magnetic Resonance Spectroscopy
24
pembrolizumab
14
trastuzumab deruxtecan
8
Radiosurgery
8
Nivolumab
8
Gemcitabine
8
Paclitaxel
7
Ipilimumab
6
Carboplatin
6
Capecitabine
6
palbociclib
5
X-Rays
5
Taxes
5
Radiation
5
Leucovorin
5
Fulvestrant
5
Fluorouracil
5
Pemetrexed
4
Oxaliplatin
4
Letrozole
4
Irinotecan
4
CTLA-4 Antigen
4
Bevacizumab
4
130-nm albumin-bound paclitaxel
4
ribociclib
3
olaparib
3
ipatasertib
3
enzalutamide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Exercise
×
30 days
×
Clear all
No trials found.